ALT FY 2017 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$331M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$41,503-99.2% YoY

Gross Profit

-$18M-44249.4% margin

Operating Income

-$52M-125401.2% margin

Net Income

-$46M-111860.3% margin

EPS (Diluted)

$-108.77

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$63M

Total Liabilities

$14M

Stockholders' Equity

$49M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41,503	$5M	-99.2%
Gross Profit	-$18M	-$2M	-822.3%
Operating Income	-$52M	-$11M	-362.0%
Net Income	-$46M	$194M	-123.9%